Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor κB activation in mouse colonocytes

Gastroenterology

Volumn 116, Issue 3, 1999, Pages 602-609

  Kaiser, G C ^a   Yan, F ^a   Polk, D B ^a  

^a S 4322 MCN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESALAZINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; COLON; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GROWTH INHIBITION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; INTESTINE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033047588     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70182-4     Document Type: Article

References (52)

1. RB. Sartor Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease Gastroenterol Clin North Am 24 1995 475 507
2. RA Heller M. Kronke Tumor necrosis factor receptor-mediated signaling pathways J Cell Biol 126 1994 5 9
3. H Loetscher EJ Schlaeger HW Lahm YCE Pan W Lesslauer M. Brockman Purification and partial amino acid sequence analysis of two distinct tumor necrosis factor receptors from HL60 cells J Biol Chem 265 1990 20131 20138
4. SR Targan SB Hanauer SJH VanDeventer L Mayer DH Present T Braakman KL DeWoody TF Schaible PJ. Rutgeerts A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease N Engl J Med 337 1997 1029 1035
5. B Derkx J Taminiau S Radema A Stronkhorst C Wortel G Tytgat S. Van Deventer Tumour necrosis factor antibody treatment in Crohn's disease Lancet 342 1993 173 174
6. HM Van Dullemen SJH Van Deventer DW Hommes HA Bijl J Jansen GNJ Tytgat J. Woody Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2) Gastroenterology 109 1995 129 135
7. SE Plevy SR Targan H Yang D Fernandez JI Rotter H. Toyoda Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6 Gastroenterology 110 1996 1053 1060
8. M Neurath I Fuss M Pasparkis L Alexopoulou S Haralambous KH Zum Buschenfelde W Strober G. Kollias Predominant pathogenic role of tumor necrosis factor alpha in experimental colitis Eur J Immunol 27 1997 1743 1750
9. GC Kaiser DB. Polk Tumor necrosis factor α regulates proliferation in a mouse intestinal cell line Gastroenterology 112 1997 1231 1240
10. MA Raines RN Kolesnick DW. Golde Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells J Biol Chem 268 1993 14572 14575
11. S Traverse K Seedorf H Paterson CJ Marshall P Cohen A. Ullrich EGF triggers neuronal, differentiation of PC12 cells that overexpress the EGF receptor Curr Biol 4 1994 694 701
12. FK Racke K Lewandowska S Goueli AN. Goldfarb Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells J Biol Chem 272 1997 23366 23370
13. PJ Barnes M. Karin Nuclear factor κB: a pivotal transcription factor in chronic inflammatory diseases N Engl J Med 336 1997 1066 1071
14. S Schutze K Potthoff T Machleidt D Berkovic K Wiegman M. Kronke TNF activates NFκB by phosphatidylcholine-specific phospholipase C-induced “acidic” sphinomyelin breakdown Cell 71 1992 765 776
15. ZJ Chen L Parent T. Maniatis Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity Cell 84 1996 853 862
16. Z Chen J Hagler VJ Palombella F Melandri D Scherer D Ballard T. Maniatis Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway Genes Dev 9 1995 1586 1597
17. T. Maniatis Catalysis by a multiprotein IκB kinase complex Science 278 1997 818 819
18. F Casellas M Papo F Guarner M Antolin JR Armengol J-R. Malagelada Intraluminal colonic release of immunoreactive tumour necrosis factor in chronic ulcerative colitis Clin Sci 87 1994 453 458
19. D Chen G Radford-Smith MC Dipaolo I McGowan DP. Jewell Cytokine gene transcription of human colonic intraepithelial lymphocytes cosimulated with epithelial cells bearing HLA-DR and its inhibition by 5-aminosalicyclic acid J Clin Immunol 16 1996 237 241
20. F Shanahan A Niederlehner N Carramanzana P. Anton Sulfasalazine inhibits the binding of TNF-α to its receptor Immunopharmacology 20 1990 217 224
21. P Schwenger EY Skolnik J. Vilcek Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate J Biol Chem 271 1996 8089 8094
22. E Kopp S. Ghosh Inhibition of NF-κB by sodium salicylate and aspirin Science 265 1994 956 958
23. RH Whitehead PE VanEeden MD Noble P Ataliotis PS. Jat Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb -tsA58 transgenic mice Proc Natl Acad Sci USA 90 1993 587 591
24. PS Jat MD Noble P Ataliotis Y Tanaka N Yannoutsos L Larsen D. Koussis Direct derivation of conditionally immortal cell lines from an H-2Kb -tsA58 transgenic mouse Proc Natl Acad Sci USA 88 1991 5096 5100
25. DB Polk GW McCollum G. Carpenter Cell density dependent regulation of PLCγ1 tyrosine phosphorylation and catalytic activity in an intestinal cell line (IEC-6) J Cell Physiol 162 1995 427 433
26. EK. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
27. PA. Maher Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2 J Cell Biol 134 1996 529 536
28. E Coroneos Y Wang JR Panuska DJ Templeton M. Kester Sphingolipid metabolites differentially regulate extracellular signal regulated kinase and stress-activated protein kinase cascades Biochem J 316 1996 13 17
29. S Pyne J Chapman L Steele NJ. Pyne Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase-2 (ERK-2) and c-jun n-terminal kinase (JNK) signal cascades in airway smooth muscle Eur J Biochem 237 1996 819 826
30. H. Allgayer Sulfasalazine and 5-ASA compounds Gastroenterol Clin North Am 21 1992 643 658
31. TS Gaginella RE. Walsh Sulfasalazine: multiplicity of action Dig Dis Sci 37 1992 801 812
32. M Watanabe Y Ueno T Yajima Y Iwao M Tsuchiya H Ishikawa S Aiso T Hibi H. Ishii Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes J Clin Invest 95 1995 2945 2953
33. S Hobbie LM Chen RJ Davis JE. Galan Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells J Immunol 59 1997 5550 5559
34. H Komano Y Fujiura M Kawaguchi S Matsumoto Y Hashimoto S Obana P Mombaerts S Tonegawa H Yamamoto S Itohara M Nanno H. Ishikawa Homeostatic regulation of intestinal epithelia by intraepithelial γδ T cells Proc Natl Acad Sci USA 92 1995 6147 6151
35. P Lollini A D'Errico C DeGiovanni L Landuzzi F Frabetti G Nicoletti F Cavallo M Giovarelli W Grigioni P. Nanni Systemic effects of cytokines released by gene-transduced tumor cells: marked hyperplasia induced in small bowel by γ interferon transfectants through host lymphocytes Int J Cancer 61 1995 425 430
36. FM Thompson G Mayrhofer AG. Cummins Dependence of epithelial growth of the small intestine on T-cell activation during weaning in the rat Gastroenterology 111 1996 37 44
37. M Peppercorn P. Goldman Distribution studies of salicylazosulfapyridine and its metabolites Gastroenterology 64 1973 240 245
38. SJ. Konturek Role of growth factors in gastroduodenal protection and healing of peptic ulcers Gastroenterol Clin North Am 19 1990 41 65
39. B Egger F Procaccino J Lakshmanan M Reinshagen P Hoffmann A Patel W Reuben S Gnanakkan L Liu L Barajas VE. Eysselein Mice lacking transforming growth factor α have an increased susceptibility to dextran sulfate-induced colitis Gastroenterology 113 1997 825 832
40. F Procaccino M Reinshagen P Hoffmann JM Zeeh J Lakshmanan JA McRoberts A Patel S French VE. Eysselein Protective effect of epidermal growth factor in an experimental model of colitis in rats Gastroenterology 107 1994 12 17
41. C Wahl S Liptay G Adler RM. Schmid Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B J Clin Invest 101 1998 1163 1174
42. W Beeken D Howard J Begelow T Trainer M Roy W Thayer G. Wild Controlled trial of 4-ASA in ulcerative colitis Dig Dis Sci 42 1997 354 358
43. R Kolesnick Z. Fuks Ceramide: a signal for apoptosis or mitogenesis? J Exp Med 181 1995 1949 1952
44. Y Zhang B Yao S Delikat S Bayuomy X Lin S Basu M McGinley P Chan-Hui H Lichenstein R. Kolesnick Kinase suppressor of ras l/s ceramide-activated protein kinase Cell 89 1997 63 72
45. K Wiegmann S Schutze T Machleidt D Witte M. Kronke Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling Cell 78 1994 1005 1015
46. AS. Baldwin Jr The NF-κB and IκB proteins: new discoveries and insights Annu Rev Immunol 14 1996 649 681
47. LD Johns T Sarr GE. Ranges Inhibition of ceramide pathway does not affect ability of TNF-α to activate nuclear factor-κB J Immunol 152 1994 5877 5882
48. F Mercurio H Zhu BW Murray A Shevchenko BL Bennett JW Li DB Young M Barbosa M Mann A Manning A. Rao IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation Science 278 1997 860 866
49. G Rogler K Brand D Vogl S Page R Hofmeister T Andus R Knuechel PA Baeuerle J Scholmerich V. Gross Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa Gastroenterology 115 1998 357 369
50. N Auphan JA DiDonato C Rosette A Helmberg M. Karin Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis Science 270 1995 286 290
51. S Heck K Bender M Kullmann M Gottlicher P Herrlich ACB. Cato IκBα-independent down-regulation of NF-κB activity by glucocorticoid receptor EMBO J 16 1997 4698 4707
52. E Ardite J Panes M Miranda A Salas JI Elizalde M Sans Y Arce JM Bordas JC Fernandez-Checa JM. Pique Effects of steroid treatment on activation of nuclear factor κB in patients with inflammatory bowel disease Br J Pharmacol 124 1998 431 433